Literature DB >> 7587712

Estimation of fetal hemoglobin levels in individual red cells via fluorescence image cytometry.

K Horiuchi1, M L Osterhout, H Kamma, N A Bekoe, K J Hirokawa.   

Abstract

A method for estimating fetal hemoglobin (Hb F) levels in individual red blood cells was developed. Cell smears were prepared using a slide maker to ensure uniform thickness and were then stained with immunofluorescence. An antifading gel was applied to preserve a stable fluorescence. The total fluorescence intensities from the same number of red cells in different slide specimens correlated with their hemolysate Hb F levels, which were determined via column chromatography (R = 0.95). Hb F level in individual cells was estimated from fluorescence intensity and cell area, which were determined via image analysis techniques and the hemolysate Hb F level. Blood from a normal subject, a subject with hereditary persistence of fetal hemoglobin, and from sickle cell patients with varying Hb F levels was analyzed. Our analyses showed a wide distribution of Hb F among cells for the normal subject and a gaussian distribution with a peak at the hemolysate Hb F level for the subject with hereditary persistence of fetal hemoglobin. The Hb F distributions were unique to the patients with sickle cell disease. Because Hb F level in individual sickle cells is crucial to the inhibition of cell sickling, the unique hb F distribution may be important in determining the clinical course of this disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7587712     DOI: 10.1002/cyto.990200310

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  7 in total

1.  Effect of fetal hemoglobin on microvascular regulation in sickle transgenic-knockout mice.

Authors:  Dhananjay K Kaul; Xiao-du Liu; Hee-Yoon Chang; Ronald L Nagel; Mary E Fabry
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

Review 2.  Fetal hemoglobin in sickle cell anemia.

Authors:  Martin H Steinberg
Journal:  Blood       Date:  2020-11-19       Impact factor: 22.113

3.  Correction of murine hemoglobinopathies by prenatal tolerance induction and postnatal nonmyeloablative allogeneic BM transplants.

Authors:  William H Peranteau; Satoshi Hayashi; Osheiza Abdulmalik; Qiukan Chen; Aziz Merchant; Toshio Asakura; Alan W Flake
Journal:  Blood       Date:  2015-06-29       Impact factor: 22.113

4.  No improvement in suboptimal vitamin A status with a randomized, double-blind, placebo-controlled trial of vitamin A supplementation in children with sickle cell disease.

Authors:  Kelly A Dougherty; Joan I Schall; Deborah A Kawchak; Michael H Green; Kwaku Ohene-Frempong; Babette S Zemel; Virginia A Stallings
Journal:  Am J Clin Nutr       Date:  2012-09-05       Impact factor: 7.045

Review 5.  Heterogeneity of fetal hemoglobin production in adult red blood cells.

Authors:  Eugene Khandros; Gerd A Blobel
Journal:  Curr Opin Hematol       Date:  2021-05-01       Impact factor: 3.284

Review 6.  High Foetal Haemoglobin in Sickle Cell Disease: Not so Protective?

Authors:  Nicola Conran
Journal:  EBioMedicine       Date:  2015-01-14       Impact factor: 8.143

Review 7.  Hydroxycarbamine: from an Old Drug Used in Malignant Hemopathies to a Current Standard in Sickle Cell Disease.

Authors:  Giovanna Cannas; Solène Poutrel; Xavier Thomas
Journal:  Mediterr J Hematol Infect Dis       Date:  2017-02-15       Impact factor: 2.576

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.